Icon Legend

This session is not on your agenda.

This session is on your agenda. Click again to remove it.

Presentation Icons

ACVIM Resident Research Award Eligible

Additional Fees May Be Required

By Invite Only

Capturing for On Demand

Cardiology Research Abstract Award Eligible

ERC Approved Lecture for ACVIM Residency

Poster

Livestream

One Health

Pre-Registration Required

Research Abstract

Specialty Symposium

ACVIM Resident Research Award Winner

Cardiology Research Abstract Award Winner

Back

129 Views

Evaluation ViewAttendees 8

Small Animal Internal Medicine

In Person Only

Clinical Management of Extensively Resistant Gram-negative Infections: Carbapenem-resistant Enterobacterales and ESBLs

ABVP Track

Thursday, June 6, 2024

10:00am – 11:00am CT

Location: MCC 211 B

CE: 1.0

Primary Presenter(s)

Cooper Brookshire, DVM, MS, DACVPM, DABVP (Canine and Feline Practice)

Assistant Clinical Professor
Mississippi State University, College of Veterinary Medicine
Starkville, Mississippi, United States

Proceedings/Handout

Disclosure(s):

Cooper Brookshire, DVM, MS, DACVPM, DABVP (Canine and Feline Practice): No financial relationships to disclose

This lecture will review the clinical management of extensively resistant gram-negative infections in companion animals. The primary two type of pathogens will include extended-spectrum β-lactamase producing (ESBLs) and carbapenem-resistant Enterobacterales (CRE). ESBLs have been common for many years, but recent reports suggest that CRE have recently emerged as clinical pathogens, particularly in tertiary referral centers. Topics covered will include background information about pathogens, new antibiotic susceptibility testing changes that impact treatment of many infections, treatment with commonly utilized antibiotics, and treatment with less-common antibiotics.

Learning Objectives:

Recognize ESBL and CRE infections
Understand why bacteria are being reported as resistant more commonly on antibiotic susceptibly tests for certain antibiotics
Clinically manage ESBL and CRE infections